Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Covalys Biosciences was a Swiss biotechnology company specializing in advanced protein labeling and imaging technologies for life science research. The company is most recognized for developing the SNAP-tag and CLIP-tag systems, which enable the specific and covalent labeling of fusion proteins with various chemical probes, such as fluorophores or biotin. These tools significantly advanced the study of protein function, localization, and dynamics within living cells and in vitro environments. Founded as a spin-off from the École Polytechnique Fédérale de Lausanne (EPFL), Covalys provided researchers with a versatile platform for high-resolution imaging and protein immobilization. In 2009, the company was acquired by New England Biolabs, which integrated the technology into its extensive portfolio of molecular biology reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Covalys Biosciences.